Table 1.
Baseline Characteristics of Adult Federally Qualified Health Center Patients*
| Characteristic | Eligible for Screening, n (%)† |
Ineligible for Screening, n (%) |
|---|---|---|
| Number | 89,543 (100) | 93,786 (100) |
| Mean age, years | 49.1 (9.4) | 36.1 (15.9) |
| Age categories, years | ||
| 18–34 | 0 (0.0) | 63,524 (67.7) |
| 35–39 | 17,242 (19.3) | 4,536 (4.8) |
| 40–49 | 31,387 (35.1) | 6,904 (7.4) |
| 50–64 | 35,170 (39.3) | 10,624 (11.3) |
| 65–70 | 5,744 (6.4) | 2,126 (2.3) |
| 70 + | 0 (0.0) | 6,072 (6.5) |
| Sex | ||
| Male | 39,376 (44.0) | 42,461 (45.3) |
| Female | 50,167 (56.0) | 51,325 (54.7) |
| Race and ethnicity | ||
| Non-Hispanic Asian | 2,798 (3.1) | 3,146 (3.4) |
| Non-Hispanic Black | 24,831 (27.7) | 26,017 (27.7) |
| Hispanic/Latino | 33,007 (36.9) | 32,127 (34.3) |
| Non-Hispanic White | 24,728 (27.6) | 28,285 (30.1) |
| Other or unknown | 4,179 (4.7) | 4,211 (4.5) |
| Insurance status | ||
| Uninsured | 30,849 (34.5) | 25,439 (27.1) |
| Medicaid | 20,937 (23.4) | 28,235 (30.1) |
| Medicare | 5,311 (5.9) | 5,303 (5.7) |
| Private | 17,172 (19.2) | 19,026 (20.3) |
| Other or unknown | 15,274 (17.1) | 15,783 (16.8) |
| Family history of diabetes | 2,511 (3.0) | 2,970 (3.2) |
| Hypertension | 64,627 (72.2) | 53,833 (57.4) |
| Dyslipidemia | 42,130 (47.1) | 24,831 (26.5) |
| Polycystic ovary syndrome‡ | 333 (0.7) | 1,821 (3.5) |
| Mean body mass index, kg/m2 | 32.5 (6.5) | 27.8 (7.6) |
| Weight status | ||
| Normal | 0 (0.0) | 45,291 (48.3) |
| Overweight | 36,984 (41.3) | 19,580 (20.9) |
| Class 1 obesity | 28,275 (31.6) | 14,140 (15.1) |
| Class 2 obesity | 13,729 (15.3) | 7,595 (8.1) |
| Class 3 obesity | 10,555 (11.8) | 7,180 (7.7) |
| Mean baseline number of office visits§ | 3.2 (5.5) | 3.8 (5.7) |
| 0 baseline visits | 46,136 (51.5) | 40,082 (42.7) |
| 1 baseline office visit | 6,221 (6.9) | 7,801 (8.3) |
| 2–3 baseline office visits | 10,532 (11.8) | 12,990 (13.9) |
| ≥ 4 baseline office visits | 26,654 (29.8) | 32,913 (35.1) |
* Unless noted otherwise, data are presented as column percentages for each of the patient characteristics. Percentages may not add to 100 due to rounding within strata of patient characteristics
† Screening eligibility was determined according to the 2021 USPSTF recommendation, namely age 35–70 years old and overweight or obesity
‡ The denominator for the reported proportions was the total number of women
§ The number of baseline office visits was determined during the three years preceding the study period (i.e., January 1, 2015-December 31, 2017), during which glycemic status was ascertained